CEUEX
Price
$60.64
Change
-$0.15 (-0.25%)
Updated
Jul 2 closing price
Net Assets
143.2B
RERAX
Price
$57.93
Change
-$0.15 (-0.26%)
Updated
Jul 2 closing price
Net Assets
143.2B
Interact to see
Advertisement

CEUEX vs RERAX

CEUEX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
CEUEX vs. RERAX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUEX is a Buy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUEX (143B) and RERAX (143B) have equal amount of cash in the bank . CEUEX pays higher dividends than RERAX: CEUEX (2.44) vs RERAX (2.25). CEUEX was incepted earlier than RERAX: CEUEX (24 years) vs RERAX (24 years). RERAX (1.57) is less costly to investors than CEUEX (1.09). CEUEX (50.00) and RERAX (50.00) have comparable annual turnover. CEUEX (250) and RERAX (250) have matching initial minimum investment requirements. CEUEX annual gain was more profitable for investors over the last year : 6.13 vs. RERAX (4.99). CEUEX return over 5 years is better than : -5.70 vs. RERAX (-9.47).
CEUEXRERAXCEUEX / RERAX
Total Expense Ratio1.091.5769%
Annual Report Gross Expense Ratio1.091.5769%
Fund Existence24 years24 years-
Gain YTD3.7293.207116%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets143B143B100%
Annual Yield % from dividends2.442.25108%
Returns for 1 year6.134.99123%
Returns for 3 years19.9217.10117%
Returns for 5 years-5.70-9.4760%
Returns for 10 years55.7642.88130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSEDX20.830.09
+0.43%
Columbia Intrinsic Value Institutional 2
OCIEX17.710.02
+0.11%
Optimum International C
LRSOX24.08-0.17
-0.70%
Lord Abbett Small Cap Value F3
AMALX12.49-0.11
-0.87%
American Century Small Cap Dividend G
FEMSX30.76-0.61
-1.94%
Fidelity Series Emerging Markets Opps